Mr Simon Brewster

Bsc, MD, FRCS (Urol)

Consultant Urologist

Special clinical interest in prostate cancer and other prostate disease (PSA kinetics, benign prostatic hyperplasia (BPH), prostatitis)

Simon Brewster is a senior Consultant Urologist and prostate gland specialist in Oxfordshire. Simon specialises in prostate cancer and other prostate disease (PSA kinetics, benign prostatic hyperplasia (BPH), prostatitis). He is trained as a general urologist and treats a variety of conditions including urinary tract symptoms, blood in the urine (haematuria), bladder cancer and recurrent urinary infections.

Training and Experience

Simon qualified in medicine at Charing Cross Hospital in 1986, with honours in Pathology and a 1st class Bsc. degree in Anatomy. He moved to Bristol to train in surgery and specialised in urology. He developed his interest in prostate disease, having spent two years in full-time laboratory research, leading to the award of his MD doctorate thesis in 1993. In 1997 he attained the FRCS (Urology) and went to John Hopkins Hospital, Baltimore to develop expertise in radical prostatectomy with Dr Patrick Walsh.

In 1998, Simon was appointed as a consultant in Oxford, where he pioneered the prostate cancer diagnostic and active surveillance services, radical prostatectomy, and Holmium laser enucleation of the prostate (HoLEP). He has led on prostate cancer service provision and clinical governance for the NHS urology department in Oxford. He was Chair of the Thames Valley Cancer Network Urology steering group 2008-13, with responsibilities to advise commissioners and ensure equal provision of regional NHS cancer services. He is currently serving as an elected clinical staff Governor of the Oxford University Hospitals NHS Foundation Trust.

Simon contributes to the content of several patient information booklets and webpages produced by Prostate Cancer UK and helped to found the Oxfordshire Prostate Cancer Support Group in 2010. He is a member of the British Association of Urological Surgeons (BAUS) and the American Urological Association (AUA).

As of January 2018, he trained to perform the NICE-approved “SpaceOAR” gel injection (IPG590) for patients about to undergo beam radiotherapy for prostate cancer at GenesisCare.

As of January 2019 he trained to provide the NICE-approved Rezum daycase procedure (MIB158) – ablation of BPH/ prostate enlargement using steam for self-pay and insured patients, as well as the highly-acclaimed Holmium laser prostate enucleation (HoLEP).

Awards received

  • British Association of Urological Surgeons (BAUS): Elected Executive Board member, Section of Oncology and Office of Education 2010 – 2015.
  • European Association of Urology (EAU): Executive Board member, Section of Onco-Urology (ESOU) 2008-2013

Clinical interests

Prostate cancer and other prostate disease (PSA kinetics, benign prostatic hyperplasia (BPH), prostatitis), urinary tract symptoms, blood in the urine (haematuria), bladder cancer and recurrent urinary infections.

Research Interests

Simon has written 90 peer-reviewed papers and has contributed to two textbooks, including the successful Oxford Handbook of Urology, now in its 4th edition.

He contributes to clinical audit and trials, including the use of MRI scanning in the diagnosis of prostate cancer. He is an assigned educational supervisor for surgeons in training and a Fellow of Hertford College (University of Oxford) where he provides its medical students with clinical teaching, educational supervision and pastoral support.

Professional memberships

  • FRCS (Urol)Combined Royal Colleges of Surgeons of the UK and Ireland 1997
  • Doctor of MedicineUniversity of Bristol 1993
  • MB BS (hons)University of London 1986
  • Bsc in Anatomy 1st class honoursUniversity of London 1983